InSilicoTrials
InSilicoTrials offers a platform that speeds drug and medical device R&D by enabling virtual trials and predictive simulations. It delivers a cloud-based B2B SaaS solution combining a library of computational models, AI-driven analytics, and digital patient twins to simulate efficacy, safety, and trial scenarios. Users—primarily pharmaceutical, biotech, and MedTech teams—run in silico studies to inform trial design, generate regulatory-relevant evidence, and prioritize candidates. The platform supports integration into R&D and regulatory workflows and is used to reduce early-stage human testing, shorten development timelines, and explore personalized and rare-disease strategies.
InSilicoTrials
InSilicoTrials offers a platform that speeds drug and medical device R&D by enabling virtual trials and predictive simulations. It delivers a cloud-based B2B SaaS solution combining a library of computational models, AI-driven analytics, and digital patient twins to simulate efficacy, safety, and trial scenarios. Users—primarily pharmaceutical, biotech, and MedTech teams—run in silico studies to inform trial design, generate regulatory-relevant evidence, and prioritize candidates. The platform supports integration into R&D and regulatory workflows and is used to reduce early-stage human testing, shorten development timelines, and explore personalized and rare-disease strategies.
TL;DR
What they do: Cloud platform for mechanistic/statistical modeling, virtual patient simulations, and digital twins to support drug and medical-device R&D and regulatory decisions
Headquarters: Trieste, Italy
Founded: 2018
Customers: Pharma, biotech, and MedTech organizations (B2B SaaS)
Notable tech: Virtual clinical trials, synthetic control arms, digital patient twins
Company Overview
Problem Domain
Drug and medical device development — improving prediction of safety, efficacy, and trial design via in silico simulation.
Founded
2018
Industry
Biotechnology
Tech Stack
Funding Track Record
Grant listed as a financing event
Investor Signal
“Includes investors such as Pi Campus, United Ventures, StartUp Health, and Advanced Research Projects Agency for Health”